BioMarin

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade BioMarin 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. 

CEO
Alexander Hardy
CEOAlexander Hardy
Employees
3,040
Employees3,040
Headquarters
San Rafael, California
HeadquartersSan Rafael, California
Founded
1997
Founded1997
Employees
3,040
Employees3,040

BMRN Key Statistics

Market cap
10.91B
Market cap10.91B
Price-Earnings ratio
21.27
Price-Earnings ratio21.27
Dividend yield
Dividend yield
Average volume
2.22M
Average volume2.22M
High today
$57.31
High today$57.31
Low today
$54.20
Low today$54.20
Open price
$55.82
Open price$55.82
Volume
1.55M
Volume1.55M
52 Week high
$73.51
52 Week high$73.51
52 Week low
$50.76
52 Week low$50.76

Stock Snapshot

The current BioMarin(BMRN) stock price is $56.78, with a market capitalization of 10.91B. The stock trades at a price-to-earnings (P/E) ratio of 21.27.

As of 2026-01-27, BioMarin(BMRN) stock has fluctuated between $54.20 and $57.31. The current price stands at $56.78, placing the stock +4.8% above today's low and -0.9% off the high.

The BioMarin(BMRN)'s current trading volume is 1.55M, compared to an average daily volume of 2.22M.

During the past year, BioMarin(BMRN) stock moved between $50.76 at its lowest and $73.51 at its peak.

During the past year, BioMarin(BMRN) stock moved between $50.76 at its lowest and $73.51 at its peak.

BMRN News

Nasdaq 21h
BioMarin To Raise $850 Mln In Sr. Notes To Fund Amicus Acquisition

(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN), announced on Monday its plans to offer $850 million in senior unsecured notes due 2034. The company also launc...

BioMarin To Raise $850 Mln In Sr. Notes To Fund Amicus Acquisition

Analyst ratings

78%

of 27 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

People also own

Based on the portfolios of people who own BMRN. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.